Rockwell Medical Technologies (NASDAQ: RMTI) reported Q3 EPS of ($0.05), $0.03 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $14.4 million versus the consensus estimate of $14.93 million.

For earnings history and earnings-related data on Rockwell Medical Technologies (RMTI) click here.